Literature DB >> 22131053

Management of duodenal adenomatosis in FAP: single centre experience.

Musa Drini1, Anthony Speer, Christopher Dow, Neil Collier, Prithi Bhathal, Finlay A Macrae.   

Abstract

Duodenal and ampullary carcinoma in familial adenomatosis (FAP) is the third leading cause of FAP related deaths. Management of this condition is a challenging. The aim of this study was to evaluate the role of multiple targeted endoscopic biopsies and macroscopic appearance as the major determinants for surgical intervention. A secondary aim was to assess histological heterogeneity through comparing endoscopic biopsies and describe the clinical outcomes of our cohort after intervention. We reviewed our FAP surveillance database of 67 patients, between January 1999--June 2011 undergoing upper GI surveillance and where indicated, subsequent surgical intervention. Among 67 patients, 11 underwent surgical resection. Pancreas-preserving duodenectomy was performed in four patients (five procedures), and Whipple's operation in seven patients. The average size of polyps was 43 mm (range 17-65 mm), and the average number of targeted endoscopic biopsies per lesion was 7.5 (range 5-10). Two cases of high-grade (severe) dysplasia were diagnosed on endoscopic biopsies each understaged compared with the subsequent surgical specimen. All carcinomas identified have been resectable with no evidence of local spread or distant metastasis. There was one postoperative death, but no cancer related deaths. We identified both cancers at an early stage and there were no missed or late diagnoses. There have been no recurrences of carcinoma in a more than 7 years follow-up. Due to the heterogeneous nature of these lesions, comprehensive macroscopic assessment should be complemented with multiple targeted biopsies to improve the chance of early detection of advanced lesions.

Entities:  

Mesh:

Year:  2012        PMID: 22131053     DOI: 10.1007/s10689-011-9496-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  20 in total

1.  Adenoma and carcinoma of the duodenum and papilla of Vater: a clinicopathologic study.

Authors:  E Seifert; F Schulte; M Stolte
Journal:  Am J Gastroenterol       Date:  1992-01       Impact factor: 10.864

2.  Upper gastrointestinal neoplasia in familial polyposis.

Authors:  R C Kurtz; S S Sternberg; H H Miller; J J Decosse
Journal:  Dig Dis Sci       Date:  1987-05       Impact factor: 3.199

3.  Prophylactic pancreaticoduodenectomy for premalignant duodenal polyposis in familial adenomatous polyposis.

Authors:  S Causeret; Y François; J B Griot; B Flourie; F N Gilly; J Vignal
Journal:  Int J Colorectal Dis       Date:  1998       Impact factor: 2.571

4.  Pancreas-sparing duodenectomy is effective management for familial adenomatous polyposis.

Authors:  Richard Mackey; R Matthew Walsh; Raphael Chung; Nancy Brown; Andrew Smith; James Church; Carol Burke
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

5.  Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.

Authors:  C J Yeo; J L Cameron; T A Sohn; K D Lillemoe; H A Pitt; M A Talamini; R H Hruban; S E Ord; P K Sauter; J Coleman; M L Zahurak; L B Grochow; R A Abrams
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

6.  Adenomas of the small intestine: a clinicopathologic review of 51 cases and a study of their relationship to carcinoma.

Authors:  K H Perzin; M F Bridge
Journal:  Cancer       Date:  1981-08-01       Impact factor: 6.860

7.  Carcinoma of the ampulla of vater. A clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenoma.

Authors:  K Yamaguchi; M Enjoji
Journal:  Cancer       Date:  1987-02-01       Impact factor: 6.860

8.  Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate.

Authors:  M L Bisgaard; K Fenger; S Bülow; E Niebuhr; J Mohr
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

9.  Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis.

Authors:  M C Gallagher; A Shankar; C J Groves; R C G Russell; R K S Phillips
Journal:  Br J Surg       Date:  2004-09       Impact factor: 6.939

10.  Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis.

Authors:  W H de Vos tot Nederveen Cappel; H J Järvinen; J Björk; T Berk; G Griffioen; H F A Vasen
Journal:  Br J Surg       Date:  2003-06       Impact factor: 6.939

View more
  3 in total

Review 1.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

Review 2.  Duodenal adenoma surveillance in patients with familial adenomatous polyposis.

Authors:  Fábio Guilherme Campos; Marianny Sulbaran; Adriana Vaz Safatle-Ribeiro; Carlos Augusto Real Martinez
Journal:  World J Gastrointest Endosc       Date:  2015-08-10

3.  Risk factors for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis: a prospective, single-center study.

Authors:  M Sulbaran; F G Campos; U Ribeiro; H S Kishi; P Sakai; E G H de Moura; L Bustamante-López; M Tomitão; S C Nahas; I Cecconello; A V Safatle-Ribeiro
Journal:  Endosc Int Open       Date:  2018-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.